Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

DETECTION OF AUTOLOGOUS BLOOD DOPING

View ORCID ProfileChrister Malm, View ORCID ProfileIrene Granlund, Michael Hall, Pernilla Lindén, View ORCID ProfileMagnus Ericsson, View ORCID ProfileJames I. Langridge, View ORCID ProfileLee A. Gethings, View ORCID ProfileChris Hughes, View ORCID ProfileNelson Khoo
doi: https://doi.org/10.1101/2020.07.04.20146217
Christer Malm
1Section of Sports Medicine, Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden
2Pro Test Diagnostics AB, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christer Malm
  • For correspondence: christer.malm@umu.se
Irene Granlund
2Pro Test Diagnostics AB, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Irene Granlund
Michael Hall
2Pro Test Diagnostics AB, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pernilla Lindén
2Pro Test Diagnostics AB, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magnus Ericsson
3AFLD - Agence Française de Lutte contre le Dopage, Département des analyses, Châtenay-Malabry, France
4Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Magnus Ericsson
James I. Langridge
5Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James I. Langridge
Lee A. Gethings
5Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lee A. Gethings
Chris Hughes
5Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chris Hughes
Nelson Khoo
2Pro Test Diagnostics AB, Umeå, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nelson Khoo
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Autologous blood transfusion (ABT) enhances athlete’s performance, is banned as doping by the World Anti-Doping Agency (WADA). Currently, there is no implemented detection method for ABT. Transfusion of one’s own, long-term cryopreserved red blood cells (cryo-RBC) immediately increases circulating RBC count, hemoglobin mass, blood volume and oxygen carrying capacity, resulting in enhanced physical performance. Functional viablity of cryo-RBC are maintained for decades, but storage lesions lead to removal of damaged RBC from circulation days after transfusion, with remaining circulating cryo-RBC displaying normal half-life.

Methods The cytosolic RBC peptidome from 22 human subjects (12 men and 10 women) was analyzed by UHPLC-MS/MS before and after ABT with cryo-RBC. As a control group and for investigation of confounders, 14 elite athletes and 5 recreational subjects were sampled multiple times, also at high altitude.

Results Here we report alteration in the cytosolic peptidome of circulating RBC weeks after ABT, discriminating doped from non-doped human subjects. A valid discriminating multivariate model (OPLS-DA) based on <200 peptides was accomplished (R2/Q2 = 0.88/0.59, P CV-ANOVA < 0.0001, ROC AUC = 0.97). Models did not show bias for sex, high altitude or elite endurance training and racing.

Conclusion Identified peptides with low intra- and inter-individual variation, and high multivariate model weight and probability scores, create a direct method for the detection of autologous blood doping.

Competing Interest Statement

CM, IG and NK are part owners of Pro Test Diagnostics AB

Funding Statement

This work was supported and funded by World Anti-Doping Agency (WADA) R07A1CM, 08C06CM and T13M04CM (http://wada-ama.org), Sweden’s Innovation Agency (VINNOVA) 2009-00462, 2013-05410, 2015-05299, 2018-01881 (http://vinnova.se), Centrum för Idrottsforskning (CIF) 2008 88/08 (http://centrumforidrottsforskning.se) and Umeå Biotech Incubator (http://ubi.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Ethics Board for Northern Sweden (DNr: Ö;1-2009, 08-196M, 2011-408-32M). All participants provided written informed consent, were screened by a hematologist physician before entering the study, and all transfusions performed according to state-approved clinical procedures at Swedish hospitals. Risks reviewed in Appendix 1. Some subjects performed maximal physical work, which may give discomfort, but activities were voluntary and could be stopped at any time. The study was conducted in accordance with the WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects 2013. Data is encrypted, stored on security protected servers. Only approved staff has access to data and code keys.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available in Supplementary files

https://www.dropbox.com/sh/vprl88p6binepmb/AACVJ-mV6jdvqvwDMGDvic30a?dl=0

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
DETECTION OF AUTOLOGOUS BLOOD DOPING
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
DETECTION OF AUTOLOGOUS BLOOD DOPING
Christer Malm, Irene Granlund, Michael Hall, Pernilla Lindén, Magnus Ericsson, James I. Langridge, Lee A. Gethings, Chris Hughes, Nelson Khoo
medRxiv 2020.07.04.20146217; doi: https://doi.org/10.1101/2020.07.04.20146217
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
DETECTION OF AUTOLOGOUS BLOOD DOPING
Christer Malm, Irene Granlund, Michael Hall, Pernilla Lindén, Magnus Ericsson, James I. Langridge, Lee A. Gethings, Chris Hughes, Nelson Khoo
medRxiv 2020.07.04.20146217; doi: https://doi.org/10.1101/2020.07.04.20146217

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Sports Medicine
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9003)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)